Leukos Biotech

We are very proud to share with such great companies this space at the Institut de Recerca contra la Leucèmia Josep Carreras.

Regulatory Science to 2025 – launch of six-month public consultation | European Medicines Agency europa.eu/!Ub93NT

We are very happy to welcome our new Lab Manager: Lise Clément-Demange. leukosbiotech.com/team/

Ruth Risueño @LeukosBiotech és un dels casos d'èxit de #techtransfer a la #BioRegioCatalunya, avui ens ho explica a la presentació de l'#InformeBiocat

A New Biology for a New Century mmbr.asm.org/content/68/2/1…

New article by Dr. Risueño's Lab and Leukos Biotech on the role of HTRs in MDS and CMML. leukosbiotech.com/news-1/2018/9/…

Leucemia, no lo olvides, vamos a por ti. Vamos a ponerte una fecha final para que todos los pacientes te sobrevivan. Necesitamos ser más contra ti. ¿Nos echas una mano? fcarreras.org/donaahora #PonleFecha

LK-01 Granted Orphan Drug Designation by the U.S. FDA for Acute Myeloid Leukemia leukosbiotech.com/news-1/2018/6/…

We want to give a very warm welcome as a new @EIT_Health_es partner to Genesis Biomed, a company specialized in providing consulting services to spin-off and start-up companies, entrepreneurs and research centres. 🗞️ Read the new at goo.gl/4FjwWC

We are hiring! leukosbiotech.com/news-1/2018/2/…

QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing in second half 2018 in Europe and later in the U.S.

We are very happy and proud! Our CSO, Dr. Ruth M. Risueño, received an accessit prize from the REAL ACADEMIA NACIONAL DE FARMACIA @RANFarmacia.

Great news! Did you know that Leukos Biotech has developed a similar test for Acute Myeloid Leukaemia? twitter.com/NatureNews/sta…

⌛️🔜 #JornadaGENESISBiomed2017 en @PCB_UB. Hablaremos de tendencias en emprendimiento #biofarma con @CaixaCR, Peptomyc, AptaTargets y @LeukosBiotech ow.ly/m1Y330fDeVn

Leukos Biotech is certified as Innovative SME leukosbiotech.com/news-1/2017/7/…

Bé, bé, bé. L'equip Spherium Biomed comença a preparar la barbacoa! #CataloniaBioBBQ @specipig

Save the date. Barcelona Peptide Therapeutics Symposium 2017, 20th September.

Meet the CEO of Minoryx, the Spanish Biotech Fighting Rare Disease labiotech.eu/interview-mino…